P766-0285 Screening compound: 1-[2-(morpholin-4-yl)ethyl]-5-[5-(1-phenylethyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazole

P766-0285 Screening compound: 1-[2-(morpholin-4-yl)ethyl]-5-[5-(1-phenylethyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazole
P766-0285 Screening compound: 1-[2-(morpholin-4-yl)ethyl]-5-[5-(1-phenylethyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazole alternative view

Chemical Structure Depiction of ChemDiv screening compound P766-0285
1-[2-(morpholin-4-yl)ethyl]-5-[5-(1-phenylethyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P766-0285

Molecular Formula

C22H24N6O2 (C22 H24 N6 O2)

Compound Name

1-[2-(morpholin-4-yl)ethyl]-5-[5-(1-phenylethyl)-1,2,4-oxadiazol-3-yl]-1H-1,2,3-benzotriazole

IUPAC name

1-[2-(morpholin-4-yl)ethyl]-5-[5-(1-phenylethyl)-124-oxadiazol-3-yl]-1H-123-benzotriazole

SMILES

CC(c1nc(-c(cc2)cc3c2n(CCN2CCOCC2)nn3)no1)c1ccccc1

InChI

InChI=1S/C22H24N6O2/c1-16(17-5-3-2-4-6-17)22-23-21(25-30-22)18-7-8-20-19(15-18)24-26-28(20)10-9-27-11-13-29-14-12-27/h2-8,15-16H,9-14H2,1H3/t16-/m1/s1

InChI Key

QJPICOFKVCHAQV-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD27614588

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

404.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.784

Distribution Coefficient, logD

3.780

Water Solubility, LogSw

-3.97

Polar Surface Area

68.940

Acid Dissociation Constant (pKa)

26.30

Base Dissociation Constant (pKb)

5.33

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

P766-0285 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with P766-0285 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P766-0285?
Check Price and Availability of P766-0285, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P766-0285 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P766-0285
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P766-0285
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P766-0285 available by request